Lonza Group AG (LZAGY)

Profile

https://www.lonza.com

Lonza Group AG is a Swiss multinational contract development and manufacturing organization (CDMO) serving the pharmaceutical, biotechnology, and nutrition sectors. Headquartered in Basel, Switzerland, and founded in 1897, it specializes in end-to-end solutions from early-phase discovery and custom development to large-scale manufacturing of active pharmaceutical ingredients, biologics, small molecules, cell and gene therapies, and innovative dosage forms. The company operates through key divisions including Biologics, which handles complex molecules using mammalian cells, microbes, and mRNA technologies; Small Molecules for synthesis of chemical drugs; Cell & Gene for advanced therapies and personalized medicine technologies; and Capsules & Health Ingredients for drug delivery systems. Lonza Group AG supports biopharmaceutical firms with long-term supply agreements, leveraging specialized facilities across more than 30 sites worldwide to enable commercial production while adhering to stringent regulatory standards. It plays a pivotal role in accelerating drug development and manufacturing for global pharma and nutraceutical customers, focusing on high-value life sciences applications.